GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with dasatinib

Analyse Crystal structure of the L317I mutant of the C-src tyrosine kinase domain… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3QLG
Type
protein
Length
519 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
1N1
Pockets
4 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein25941% helix, 18% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26040% helix, 17% strandP00523

Ligands and binding sites

  • 1N1 · N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19160.730.77801N1
23400.650.80471N1
31300.370.7325empty
4540.330.7714empty

Interfaces

1 interface between chains.

  • A–B · 346 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 3QLG · Crystal structure of the L317I mutant of the C-src tyrosine kinase domain complexed with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.